[Mechanism and regulation of insulin secretion in patients with organic hyperinsulinism].
D000433:1-Propanol / Q000627:therapeutic use; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D004837:Epinephrine / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005934:Glucagon / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage; D006651:Histocytochemistry; D006801:Humans; D006946:Hyperinsulinism / Q000378:metabolism* / Q000473:pathology; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000503:physiopathology*; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D013997:Time Factors; D014993:Xylitol / Q000627:therapeutic use
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D005934:Glucagon; D000433:1-Propanol; D005947:Glucose; D014993:Xylitol; D004837:Epinephrine